Cost-Effectiveness of Measles Campaigns (Archived)

STATUS: Completed (January 2011 – March 2011)  
FUNDER/S: PRICELESS-SA 
PARTNER/S: Priority Cost-effectiveness Lessons for South Africa (PRICELESS-SA); Institute for Health Metrics and Evaluation (IHME), University of Washington; National (and Provincial) Department(s) of Health; Health Systems Trust
AREA: South Africa
DESCRIPTION: Supplemental immunisation activities (SIAs) are the cornerstone of the World Health Organization’s current measles elimination strategy and have, in the last decade, provided children aged 6 months to 14 years in sub-Saharan Africa with an additional dose of measles vaccine. These campaigns typically last a few days and integrate the delivery of other child interventions such as vitamin A supplementation, deworming medications and OPV vaccines. This study aimed to produce a descriptive and economic evaluation of routine and supplemental immunisation activities in all provinces in South Africa.
OBJECTIVES:
  • Report coverage levels of first and second dose of routine measles immunisation, as well as other coverage levels of measles immunisation in the SIAs, at the province and district level for the period 2008-2010 in South Africa
  • Estimate the cost-effectiveness of these campaigns at province level in South Africa
  • Assess the opportunity costs for the health system to implement the campaigns, including the cost and impact to the health system of diverting health workers from their usual duties
PROJECT TEAM MEMBERS:
Project Manager:  Waasila Jassat

For further information contact the Project Manager, Waasila Jassat, at waasila@hst.org.za